Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
    24.
    发明授权
    Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods 有权
    取代的3,4,6,7-四氢-5H-1,2a,4a,8-四氮杂环戊二烯并[cd]

    公开(公告)号:US08178539B2

    公开(公告)日:2012-05-15

    申请号:US12440295

    申请日:2007-09-06

    IPC分类号: A61K31/4965 A61K31/497

    CPC分类号: C07D471/06

    摘要: Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalene-9-amines, pharmaceutical compositions containing the compounds or salts thereof, intermediates, methods of making the compounds or salts thereof, and methods of use of these compounds or salts thereof or pharmaceutical compositions as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 取代的3,4,6,7-四氢-5H-1,2a,4a,8-四氮杂环戊二烯并[cd] phenalene-9-胺,含有其化合物或其盐的药物组合物,中间体,制备化合物或其盐的方法 ,以及这些化合物或其盐或医药组合物作为免疫调节剂用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病的方法。

    Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
    26.
    发明授权
    Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods 失效
    取代的手性稠合[1,2]咪唑并[4,5-c]环化合物和方法

    公开(公告)号:US07906506B2

    公开(公告)日:2011-03-15

    申请号:US11827648

    申请日:2007-07-12

    IPC分类号: C07D498/14 A61K31/5365

    CPC分类号: C07D498/14

    摘要: Substituted fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines, and imidazo[4,5-c]pyridines) with a —CH(—R2)— group in the fused ring at the 2-position of the imidazo ring and a —CH(—R1)— group in the fused ring at the 1-position of the imidazo ring, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 取代的稠合[1,2]咪唑并[4,5-c]环化合物(例如咪唑并[4,5-c]喹啉,6,7,8,9-四氢咪唑并[4,5-c]喹啉,咪唑并[ 4,5-c]萘啶,6,7,8,9-四氢咪唑并[4,5-c]萘啶和咪唑并[4,5-c]吡啶)与稠合的-CH(-R 2) 在咪唑环的1位的稠合环的咪唑环的2-位上的环和-CH(-R1) - 基团,含有化合物的药物组合物,中间体,制备该化合物的方法和方法 这些化合物作为免疫调节剂的用途,用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病的疾病。

    1H-imidazo dimers
    30.
    发明授权
    1H-imidazo dimers 失效
    1H-咪唑并二聚体

    公开(公告)号:US07112677B2

    公开(公告)日:2006-09-26

    申请号:US10912908

    申请日:2004-10-08

    IPC分类号: C07D471/02

    摘要: 1H-imidazo dimer compounds are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

    摘要翻译: 1H-咪唑二聚体化合物可用作免疫应答调节剂。 本发明的化合物和组合物可以诱导各种细胞因子的生物合成,并且可用于治疗各种病症,包括病毒性疾病和肿瘤性疾病。